Pfizer Seeks Emergency Use Authorization From FDA For Investigational Covid-19 Treatment Pill
Published
Pfizer Inc. (PFE) on Tuesday submitted an application to the U.S. Food and Drug Administration for emergency authorization of its investigational Covid-19 treatment pill.
Full Article